Trap1 and Grp94 are therefore candidate alternate targets for the effects of Hsp90 inhibitors on small cell lung cancer cells both on the basis of their known affinities for Hsp90 inhibitors and their established roles in the prevention of cell death. This evidence concerns the gene HSP90B1 and small cell lung carcinoma.